Ergothioneine-Mediated Neuroprotection of Human iPSC-Derived Dopaminergic Neurons
Antioxidants · 05.06.2024 · 13 (6) · 693
DOI: 10.3390/antiox13060693 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 05.06.2024. Verfasst von Damien Meng-Kiat Leow und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117594, Singapore. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Medical Research Council, Ministry of Education, Centennial Fund.
Abstract (Originalsprache)
Cell death involving oxidative stress and mitochondrial dysfunction is a major cause of dopaminergic neuronal loss in the substantia nigra (SN) of Parkinson’s disease patients. Ergothioneine (ET), a natural dietary compound, has been shown to have cytoprotective functions, but neuroprotective actions against PD have not been well established. 6-Hydroxydopamine (6-OHDA) is a widely used neurotoxin to simulate the degeneration of dopaminergic (DA) neurons in Parkinson’s disease. In this study, we investigated the protective effect of ET on 6-OHDA treated iPSC-derived dopaminergic neurons (iDAs) and further confirmed the protective effects in 6-OHDA-treated human neuroblastoma SH-SY5Y cells. In 6-OHDA-treated cells, decreased mitochondrial membrane potential (ΔΨm), increased mitochondrial reactive oxygen species (mROS), reduced cellular ATP levels, and increased total protein carbonylation levels were observed. 6-OHDA treatment also significantly decreased tyrosine hydroxylase levels. These effects were significantly decreased when ET was present. Verapamil hydrochloride (VHCL), a non-specific inhibitor of the ET transporter OCTN1 abrogated ET’s cytoprotective effects, indicative of an intracellular action. These results suggest that ET could be a potential therapeutic for Parkinson’s disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117594, Singapore.
- Neurobiology Research Programme, Life Sciences Institute, National University of Singapore, Singapore 117456, Singapore.
- Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117596, Singapore.
- Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore 138673, Singapore.
- National Neuroscience Institute (NNI), Singapore 308433, Singapore.
- Institute of Education in Healthcare and Medical Sciences, School of Medicine, University of Aberdeen, Aberdeen AB51 7HA, UK.
ORCID-Profile: Damien Meng-Kiat Leow, Irwin Kee-Mun Cheah, Barry Halliwell, Wei-Yi Ong
Förderung
- National Medical Research Council
- Ministry of Education
- Centennial Fund
Zitieren
APA
Leow, D. M., Cheah, I. K., Chen, L., Ng, Y. K., Yeo, C. J., Halliwell, B., & Ong, W. Y. (2024). Ergothioneine-Mediated Neuroprotection of Human iPSC-Derived Dopaminergic Neurons. Antioxidants, 13(6), 693. https://doi.org/10.3390/antiox13060693
Vancouver
Leow DM, Cheah IK, Chen L, Ng YK, Yeo CJ, Halliwell B, et al. Ergothioneine-Mediated Neuroprotection of Human iPSC-Derived Dopaminergic Neurons. Antioxidants. 2024;13(6):693. doi:10.3390/antiox13060693
BibTeX
@article{Leow2024,
author = {Leow, Damien Meng-Kiat and Cheah, Irwin Kee-Mun and Chen, Lucrecia and Ng, Yang-Kai and Yeo, Crystal Jing-Jing and Halliwell, Barry and Ong, Wei-Yi},
title = {Ergothioneine-Mediated Neuroprotection of Human iPSC-Derived Dopaminergic Neurons},
journal = {Antioxidants},
year = {2024},
volume = {13},
number = {6},
pages = {693},
doi = {10.3390/antiox13060693}
}
EUVIMED